Clinical Experience of Amivantamab in EGFR+ NSCLC Patients

Opinion
Video

Dr. Kim shares his clinical experience with amivantamab in real-world practice for EGFR+ NSCLC, discussing both the benefits and challenges of incorporating it into treatment protocols.

Video content above is prompted by the following:

  • Based on your clinical experience, how has amivantamab performed in real-world practice for EGFR+ NSCLC?
  • What are the benefits and challenges you have encountered when incorporating amivantamab into treatment protocols?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Related Content